Masimo (MASI) Depreciation & Amortization (CF) (2009 - 2026)
Masimo's (MASI) quarterly Depreciation & Amortization (CF) came in at $8.1 million in Q2 2026, down 5.81% year-on-year from $8.6 million in Q2 2025, and down 40.44% quarter-over-quarter from $13.6 million in Q1 2026.
Masimo (MASI) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Masimo's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $8.1 million for Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 5.81% year-over-year to $8.1 million in Q2 2026; TTM through Apr 2026 was $38.3 million, a 18.68% decrease from a year earlier, with the FY2026 full-year figure at $38.8 million, down 20.0% from the prior year.
- Depreciation & Amortization (CF) retreated to $8.1 million in Q2 2026 per MASI's latest filing, from $13.6 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $79.5 million in Q4 2022 and bottomed at -$36.9 million in Q4 2023.
- The 5-year median for Depreciation & Amortization (CF) is $10.4 million (2024), against an average of $15.8 million.
- Biggest YoY gain for Depreciation & Amortization (CF) was 705.68% in 2022; the steepest drop was 458.46% in 2022.
- Year by year, Depreciation & Amortization (CF) stood at $79.5 million in 2022, then tumbled by 146.42% to -$36.9 million in 2023, then jumped by 148.24% to $17.8 million in 2024, then slumped by 53.93% to $8.2 million in 2025, then slipped by 1.22% to $8.1 million in 2026.
- Per Business Quant, the three latest MASI Depreciation & Amortization (CF) figures stand at $8.1 million (Q2 2026), $13.6 million (Q1 2026), and $8.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 8.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 8.10 Mn |
| Apr 4, 2026 | 8.10 Mn |
| Jan 3, 2026 | 13.60 Mn |
| Jan 3, 2026 | 13.60 Mn |
| Sep 27, 2025 | 8.20 Mn |
| Sep 27, 2025 | 8.20 Mn |
| Jun 28, 2025 | 8.40 Mn |
| Jun 28, 2025 | 8.40 Mn |
| Mar 29, 2025 | 8.60 Mn |
| Mar 29, 2025 | 8.60 Mn |
| Dec 28, 2024 | 17.80 Mn |
| Dec 28, 2024 | 17.80 Mn |
| Sep 28, 2024 | 10.30 Mn |
| Sep 28, 2024 | 10.30 Mn |
| Jun 29, 2024 | 10.40 Mn |
| Jun 29, 2024 | 10.40 Mn |
| Mar 30, 2024 | 10.00 Mn |
| Mar 30, 2024 | 10.00 Mn |
| Dec 30, 2023 | -36.90 Mn |
| Dec 30, 2023 | -36.90 Mn |